THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Opexa will be highlighted in an upcoming broadcast of “The RedChip Money Report: Small Stocks Big Money,” a nationally televised financial program. The broadcast will include an interview with Opexa’s President and Chief Executive Officer, Neil K. Warma, and is scheduled to air on Thursday, October 17th at 10:00 p.m. PDT on the Fox Business Network.
Help employers find you! Check out all the jobs and post your resume.
